$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.10 | 700 | 31,570 | 22,650 | 23.4 K to 22.7 K (-3.00 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.00 | 3,800 | 171,000 | 23,350 | 27.2 K to 23.4 K (-14.00 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.04 | 100 | 4,504 | 27,150 | 27.3 K to 27.2 K (-0.37 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.08 | 100 | 4,508 | 27,250 | 27.4 K to 27.3 K (-0.37 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.05 | 400 | 18,020 | 27,350 | 27.8 K to 27.4 K (-1.44 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | M | 36.25 | 750 | 27,188 | 27,750 | 27 K to 27.8 K (+2.78 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | M | 30.39 | 12,500 | 379,875 | 27,000 | 14.5 K to 27 K (+86.21 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 5,000 | 119,250 | 142,500 | |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 45.00 | 5,000 | 225,000 | 28,697 | 33.7 K to 28.7 K (-14.84 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 5,000 | 119,250 | 33,697 | 28.7 K to 33.7 K (+17.42 %) |
Jul 03 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 1,150 | 24,783 | 10,350 | |
Jul 03 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 41.32 | 1,150 | 47,518 | 25,366 | 26.5 K to 25.4 K (-4.34 %) |
Jul 03 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 1,150 | 24,783 | 26,516 | 25.4 K to 26.5 K (+4.53 %) |
Jul 03 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 20.31 | 2,700 | 54,845 | 10,000 | |
Jul 03 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.00 | 2,700 | 113,400 | 16,537 | 19.2 K to 16.5 K (-14.04 %) |
Jul 03 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 20.31 | 2,700 | 54,845 | 19,237 | 16.5 K to 19.2 K (+16.33 %) |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 20.31 | 7,300 | 148,285 | 12,700 | |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.01 | 420 | 17,644 | 16,537 | 17 K to 16.5 K (-2.48 %) |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.04 | 480 | 20,179 | 16,957 | 17.4 K to 17 K (-2.75 %) |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.00 | 5,280 | 221,760 | 17,437 | 22.7 K to 17.4 K (-23.24 %) |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.02 | 400 | 16,808 | 22,717 | 23.1 K to 22.7 K (-1.73 %) |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 42.03 | 720 | 30,262 | 23,117 | 23.8 K to 23.1 K (-3.02 %) |
Jul 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 20.31 | 7,300 | 148,285 | 23,837 | 16.5 K to 23.8 K (+44.14 %) |
Jun 17 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 39.70 | 750 | 29,775 | 22,573 | 23.3 K to 22.6 K (-3.22 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Option Exercise | A | 38.63 | 3,000 | 115,890 | 3,000 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 1,500 | 0 | 10,000 | 8.5 K to 10 K (+17.65 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | A | 38.63 | 7,500 | 289,725 | 7,500 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 0.00 | 2,500 | 0 | 23,323 | 20.8 K to 23.3 K (+12.01 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | A | 38.63 | 3,000 | 115,890 | 3,000 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Grant | A | 0.00 | 1,500 | 0 | 11,500 | 10 K to 11.5 K (+15.00 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | A | 38.63 | 7,500 | 289,725 | 7,500 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Grant | A | 0.00 | 2,500 | 0 | 7,967 | 5.5 K to 8 K (+45.73 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | A | 38.63 | 3,000 | 115,890 | 3,000 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Grant | A | 0.00 | 1,500 | 0 | 14,500 | 13 K to 14.5 K (+11.54 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | A | 38.63 | 7,500 | 289,725 | 7,500 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 0.00 | 2,500 | 0 | 16,537 | 14 K to 16.5 K (+17.81 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | A | 38.63 | 7,500 | 289,725 | 7,500 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 0.00 | 2,500 | 0 | 8,990 | 6.5 K to 9 K (+38.52 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 38.63 | 7,500 | 289,725 | 7,500 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 2,500 | 0 | 83,751 | 81.3 K to 83.8 K (+3.08 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | A | 38.63 | 3,000 | 115,890 | 3,000 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Grant | A | 0.00 | 1,500 | 0 | 21,500 | 20 K to 21.5 K (+7.50 %) |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 38.63 | 10,000 | 386,300 | 10,000 | |
Jun 13 2008 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 4,000 | 0 | 25,886 | 21.9 K to 25.9 K (+18.28 %) |
Jun 12 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 39.64 | 1,866 | 73,968 | 43,960 | 45.8 K to 44 K (-4.07 %) |
Jun 09 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 2,300 | 49,565 | 11,500 | |
Jun 09 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 40.00 | 2,300 | 92,000 | 25,076 | 27.4 K to 25.1 K (-8.40 %) |
Jun 09 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.50 | 2,300 | 49,450 | 27,376 | 25.1 K to 27.4 K (+9.17 %) |
Jun 05 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 35.30 | 1,134 | 40,030 | 45,826 | 47 K to 45.8 K (-2.41 %) |
May 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 36.64 | 750 | 27,480 | 20,823 | 21.6 K to 20.8 K (-3.48 %) |
Apr 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 36.73 | 750 | 27,548 | 21,573 | 22.3 K to 21.6 K (-3.36 %) |
Dec 26 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | M | 21.55 | 2,877 | 61,999 | 0 | |
Dec 26 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Sell | S | 52.00 | 2,877 | 149,604 | 20,062 | 22.9 K to 20.1 K (-12.54 %) |
Dec 26 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Buy | M | 21.55 | 2,877 | 61,999 | 22,939 | 20.1 K to 22.9 K (+14.34 %) |
Dec 20 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 50.00 | 2,500 | 125,000 | 24,986 | 27.5 K to 25 K (-9.10 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | A | 47.29 | 24,000 | 1,134,960 | 24,000 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 47.79 | 475 | 22,700 | 46,960 | 47.4 K to 47 K (-1.00 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Grant | A | 0.00 | 8,040 | 0 | 47,435 | 39.4 K to 47.4 K (+20.41 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Option Exercise | A | 47.29 | 16,500 | 780,285 | 16,500 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 47.79 | 473 | 22,605 | 20,062 | 20.5 K to 20.1 K (-2.30 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Grant | A | 0.00 | 5,500 | 0 | 20,535 | 15 K to 20.5 K (+36.58 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | Sr. VP & CSO | Payment of Exercise | F | 47.79 | 423 | 20,215 | 15,250 | 15.7 K to 15.3 K (-2.70 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | A | 47.29 | 62,500 | 2,955,625 | 62,500 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Payment of Exercise | F | 47.79 | 1,058 | 50,562 | 107,740 | 108.8 K to 107.7 K (-0.97 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Grant | A | 0.00 | 21,000 | 0 | 108,798 | 87.8 K to 108.8 K (+23.92 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 47.29 | 22,000 | 1,040,380 | 22,000 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Payment of Exercise | F | 47.79 | 815 | 38,949 | 27,486 | 28.3 K to 27.5 K (-2.88 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 7,333 | 0 | 28,301 | 21 K to 28.3 K (+34.97 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 47.29 | 18,000 | 851,220 | 18,000 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 47.79 | 566 | 27,049 | 28,697 | 29.3 K to 28.7 K (-1.93 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 6,000 | 0 | 29,263 | 23.3 K to 29.3 K (+25.79 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Chem, Dev ... | Option Exercise | A | 47.29 | 22,000 | 1,040,380 | 22,000 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Chem, Dev ... | Payment of Exercise | F | 47.79 | 291 | 13,907 | 24,778 | 25.1 K to 24.8 K (-1.16 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Chem, Dev ... | Grant | A | 0.00 | 7,333 | 0 | 25,069 | 17.7 K to 25.1 K (+41.35 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Option Exercise | A | 47.29 | 16,500 | 780,285 | 16,500 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Payment of Exercise | F | 47.79 | 279 | 13,333 | 8,531 | 8.8 K to 8.5 K (-3.17 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Grant | A | 0.00 | 5,500 | 0 | 8,810 | 3.3 K to 8.8 K (+166.16 %) |
Nov 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Option Exercise | M | 38.01 | 7,000 | 266,070 | 7,370 | |
Nov 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Sell | S | 45.00 | 7,000 | 315,000 | 3,310 | 10.3 K to 3.3 K (-67.90 %) |
Nov 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Buy | M | 38.01 | 7,000 | 266,070 | 10,310 | 3.3 K to 10.3 K (+211.48 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Sell | S | 42.00 | 2,398 | 100,716 | 15,035 | 17.4 K to 15 K (-13.76 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 40.00 | 2,500 | 100,000 | 20,968 | 23.5 K to 21 K (-10.65 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Option Exercise | M | 30.74 | 4,444 | 136,609 | 0 | |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Option Exercise | M | 21.55 | 1,332 | 28,705 | 0 | |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Sell | S | 40.00 | 1,332 | 53,280 | 3,310 | 4.6 K to 3.3 K (-28.69 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Sell | S | 42.00 | 4,444 | 186,648 | 4,642 | 9.1 K to 4.6 K (-48.91 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Buy | M | 30.74 | 4,444 | 136,609 | 9,086 | 4.6 K to 9.1 K (+95.73 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Buy | M | 21.55 | 1,332 | 28,705 | 4,642 | 3.3 K to 4.6 K (+40.24 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 29.86 | 1,415 | 42,252 | 5,000 | 3.6 K to 5 K (+39.47 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 29.82 | 785 | 23,409 | 3,585 | 2.8 K to 3.6 K (+28.04 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 29.81 | 300 | 8,943 | 2,800 | 2.5 K to 2.8 K (+12.00 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 29.79 | 500 | 14,895 | 2,500 | 2 K to 2.5 K (+25.00 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 30.59 | 41 | 1,254 | 2,000 | 2 K to 2 K (+2.09 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 30.57 | 384 | 11,739 | 1,959 | 1.6 K to 2 K (+24.38 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 30.52 | 500 | 15,260 | 1,575 | 1.1 K to 1.6 K (+46.51 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 30.54 | 75 | 2,291 | 1,075 | 1,000 to 1.1 K (+7.50 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 30.55 | 500 | 15,275 | 1,000 | 500 to 1,000 (+100.00 %) |
Aug 13 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Buy | P | 30.53 | 500 | 15,265 | 500 | 0 to 500 |
Jul 18 2007 | OSIP | OSI PHARMACEUTICAL ... | GIBSON NEIL | VP & Chief Scientif ... | Payment of Exercise | F | 33.71 | 423 | 14,259 | 15,673 | 16.1 K to 15.7 K (-2.63 %) |
Jul 18 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 33.71 | 566 | 19,080 | 23,263 | 23.8 K to 23.3 K (-2.38 %) |
Jul 18 2007 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Chem, Dev ... | Payment of Exercise | F | 33.71 | 388 | 13,079 | 17,549 | 17.9 K to 17.5 K (-2.16 %) |
Jul 18 2007 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 33.71 | 641 | 21,608 | 39,395 | 40 K to 39.4 K (-1.60 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | COSTA SANTO J | Director | Grant | A | 0.00 | 1,500 | 0 | 10,000 | 8.5 K to 10 K (+17.65 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | PINEDO HERBERT MD PHD | Director | Grant | A | 0.00 | 1,500 | 0 | 5,467 | 4 K to 5.5 K (+37.81 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 0.00 | 1,500 | 0 | 14,037 | 12.5 K to 14 K (+11.96 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Grant | A | 0.00 | 1,500 | 0 | 13,000 | 11.5 K to 13 K (+13.04 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | STEVENSON KATHARINE BERGHUIS | Director | Grant | A | 0.00 | 1,500 | 0 | 6,490 | 5 K to 6.5 K (+30.06 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 0.00 | 1,500 | 0 | 22,323 | 20.8 K to 22.3 K (+7.20 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 37.66 | 1,000 | 37,660 | 23,468 | 24.5 K to 23.5 K (-4.09 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Option Exercise | A | 36.25 | 25,000 | 906,250 | 25,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 8,500 | 0 | 8,500 | 0 to 8.5 K |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 1,500 | 0 | 81,251 | 79.8 K to 81.3 K (+1.88 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Option Exercise | A | 36.25 | 3,000 | 108,750 | 3,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | NIEMIEC DAVID W | Director | Grant | A | 0.00 | 1,500 | 0 | 20,000 | 18.5 K to 20 K (+8.11 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 6.88 | 41,000 | 281,875 | 0 | |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.36 | 74 | 2,765 | 87,798 | 87.9 K to 87.8 K (-0.08 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.35 | 482 | 18,003 | 87,872 | 88.4 K to 87.9 K (-0.55 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.27 | 100 | 3,727 | 88,354 | 88.5 K to 88.4 K (-0.11 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.26 | 500 | 18,630 | 88,454 | 89 K to 88.5 K (-0.56 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.25 | 400 | 14,900 | 88,954 | 89.4 K to 89 K (-0.45 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.24 | 200 | 7,448 | 89,354 | 89.6 K to 89.4 K (-0.22 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.23 | 4,100 | 152,643 | 89,554 | 93.7 K to 89.6 K (-4.38 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.22 | 400 | 14,888 | 93,654 | 94.1 K to 93.7 K (-0.43 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.21 | 300 | 11,163 | 94,054 | 94.4 K to 94.1 K (-0.32 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.20 | 100 | 3,720 | 94,354 | 94.5 K to 94.4 K (-0.11 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.19 | 100 | 3,719 | 94,454 | 94.6 K to 94.5 K (-0.11 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.18 | 100 | 3,718 | 94,554 | 94.7 K to 94.6 K (-0.11 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.17 | 2,550 | 94,784 | 94,654 | 97.2 K to 94.7 K (-2.62 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.16 | 100 | 3,716 | 97,204 | 97.3 K to 97.2 K (-0.10 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.15 | 3,050 | 113,308 | 97,304 | 100.4 K to 97.3 K (-3.04 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.04 | 1,200 | 44,448 | 100,354 | 101.6 K to 100.4 K (-1.18 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.99 | 10,000 | 369,900 | 101,554 | 111.6 K to 101.6 K (-8.96 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 37.07 | 1,500 | 55,605 | 111,554 | 113.1 K to 111.6 K (-1.33 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.84 | 5,000 | 184,200 | 113,054 | 118.1 K to 113.1 K (-4.24 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 36.75 | 10,744 | 394,842 | 118,054 | 128.8 K to 118.1 K (-8.34 %) |
Jun 06 2007 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 6.88 | 41,000 | 281,875 | 128,798 | 87.8 K to 128.8 K (+46.70 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 36.25 | 6,000 | 217,500 | 6,000 | |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 3,000 | 0 | 21,886 | 18.9 K to 21.9 K (+15.88 %) |
May 23 2007 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | M | 3.63 | 5,000 | 18,125 | 5,000 | |
May 23 2007 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | M | 6.75 | 5,000 | 33,750 | 0 | |
May 23 2007 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 37.78 | 100 | 3,778 | 26,203 | 26.3 K to 26.2 K (-0.38 %) |
May 23 2007 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 37.53 | 1,400 | 52,542 | 26,303 | 27.7 K to 26.3 K (-5.05 %) |
May 23 2007 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 37.54 | 500 | 18,770 | 27,703 | 28.2 K to 27.7 K (-1.77 %) |